Pediatric ID News

CDC advisors will meet next month to vote on recommendations for the updated COVID-19 vaccines that are expected to be available in the United States this fall, according to a notice published Friday in the Federal Register.

The CDC launched a new antisepsis program for U.S. hospitals that was modeled after the agency’s “Core Elements” framework for developing antibiotic stewardship programs.

Combining seasonal vaccination and chemoprevention reduces the incidence of malaria by around two-thirds compared with either prevention method by itself, updated study results confirmed.

A study of more than 30,000 hospitalized children with SARS-CoV-2 infection found that ICU admissions for COVID-19 decreased over the course of the pandemic but ventilatory and oxygen support for the youngest children did not.

Novavax on Tuesday said its updated COVID-19 vaccine candidate induced neutralizing antibodies against emerging SARS-CoV-2 subvariants in small animal and non-human primate studies.

The FDA has approved the first vaccine for pregnant people to protect infants from respiratory syncytial virus.

Moderna this week said preliminary clinical trial data confirmed that its updated COVID-19 vaccine provides a “significant boost” in neutralizing antibodies against emerging SARS-CoV-2 viruses and is expected to effectively target them.

The AAP published guidance on the use of nirsevimab, recommending it for all infants aged younger than 8 months to prevent severe disease from respiratory syncytial virus.

A national shortage of amoxicillin led to an increase in the use of alternative agents to treat ear infections, according to a study published in Pediatrics.

Maternal hepatitis B virus serostatus was not associated with pregnancy outcomes in infertile women in China who underwent freeze-thaw embryo transfer, according to data in JAMA Network Open.